Table of contents
Volume 96, Issue 1
Published online 9 January 2007 (1-182)
Minireviews |
Clinical Studies |
Translational Therapeutics |
Molecular Diagnostics |
Epidemiology |
Letters to the Editor |
Book Review
Review
The potential role of podoplanin in tumour invasion FREE
A Wicki and G Christofori
Br J Cancer 96: 1-5; advance online publication, December 19, 2006; doi:10.1038/sj.bjc.6603518
Minireviews
Stem cells of ependymoma FREE
H Poppleton and R J Gilbertson
Br J Cancer 96: 6-10; advance online publication, December 19, 2006; doi:10.1038/sj.bjc.6603519
Cancer risks among BRCA1 and BRCA2 mutation carriers FREE
E Levy-Lahad and E Friedman
Br J Cancer 96: 11-15; doi:10.1038/sj.bjc.6603535
Targeting BRAF in thyroid cancer FREE
A V Espinosa, L Porchia and M D Ringel
Br J Cancer 96: 16-20; advance online publication, December 19, 2006; doi:10.1038/sj.bjc.6603520
Clinical Studies
Schedule-dependent activity of 5-fluorouracil and irinotecan combination in the treatment of human colorectal cancer: in vitro evidence and a phase I dose-escalating clinical trial FREE
C Barone, M Landriscina, M Quirino, M Basso, C Pozzo, G Schinzari, G Di Leonardo, E D'Argento, N Trigila and A Cassano
Br J Cancer 96: 21-28; advance online publication, December 12, 2006; doi:10.1038/sj.bjc.6603496
A phase I trial of the selective oral cyclin-dependent kinase inhibitor seliciclib (CYC202; R-Roscovitine), administered twice daily for 7 days every 21 days FREE
C Benson, J White, J De Bono, A O'Donnell, F Raynaud, C Cruickshank, H McGrath, M Walton, P Workman, S Kaye, J Cassidy, A Gianella-Borradori, I Judson and C Twelves
Br J Cancer 96: 29-37; advance online publication, December 19, 2006; doi:10.1038/sj.bjc.6603509
Concurrent irinotecan, oxaliplatin and UFT in first-line treatment of metastatic colorectal cancer: a Phase I study FREE
H Y Sheikh, J W Valle, K Palmer, A Sjursen, O Craven, G Wilson, R Swindell and M P Saunders
Br J Cancer 96: 38-43; doi:10.1038/sj.bjc.6603521
A Phase I/II study of lomustine and temozolomide in patients with cerebral metastases from malignant melanoma FREE
J M G Larkin, S A Hughes, D A Beirne, P M Patel, I M Gibbens, S C Bate, K Thomas, T G Eisen and M E Gore
Br J Cancer 96: 44-48; advance online publication, December 5, 2006; doi:10.1038/sj.bjc.6603503
Arterial phase enhancement and body mass index are predictors of response to chemoembolisation for liver metastases of endocrine tumours FREE
F Marrache, M P Vullierme, C Roy, Y El Assoued, A Couvelard, D O'Toole, E Mitry, O Hentic, P Hammel, P Lévy, P Ravaud, P Rougier and P Ruszniewski
Br J Cancer 96: 49-55; advance online publication, December 12, 2006; doi:10.1038/sj.bjc.6603526
Specificity of serum prostate-specific antigen determination in the Finnish prostate cancer screening trial FREE
L Määttänen, M Hakama, T L J Tammela, M Ruutu, M Ala-Opas, H Juusela, P Martikainen, U-H Stenman and A Auvinen
Br J Cancer 96: 56-60; doi:10.1038/sj.bjc.6603522
Translational Therapeutics
The hollow fibre assay as a model for in vivo pharmacodynamics of fluoropyrimidines in colon cancer cells FREE
O H Temmink, H-J Prins, E van Gelderop and G J Peters
Br J Cancer 96: 61-66; advance online publication, December 19, 2006; doi:10.1038/sj.bjc.6603507
Potentiation of photodynamic therapy of cancer by complement: the effect of 
-inulin FREE
M Korbelik and P D Cooper
Br J Cancer 96: 67-72; advance online publication, December 5, 2006; doi:10.1038/sj.bjc.6603508
Complementary effects of HDAC inhibitor 4-PB on gap junction communication and cellular export mechanisms support restoration of chemosensitivity of PDAC cells FREE
O Ammerpohl, A Trauzold, B Schniewind, U Griep, C Pilarsky, R Grutzmann, H-D Saeger, O Janssen, B Sipos, G Kloppel and H Kalthoff
Br J Cancer 96: 73-81; advance online publication, December 12, 2006; doi:10.1038/sj.bjc.6603511
Molecular Diagnostics
Expression analysis of imbalanced genes in prostate carcinoma using tissue microarrays FREE
I Prowatke, F Devens, A Benner, E F Gröne, D Mertens, H-J Gröne, P Lichter and S Joos
Br J Cancer 96: 82-88; advance online publication, December 5, 2006; doi:10.1038/sj.bjc.6603490
Assessment of microsatellite instability status for the prediction of metachronous recurrence after initial endoscopic submucosal dissection for early gastric cancer FREE
T Hasuo, S Semba, D Li, Y Omori, D Shirasaka, N Aoyama and H Yokozaki
Br J Cancer 96: 89-94; advance online publication, December 19, 2006; doi:10.1038/sj.bjc.6603532
Hypoxia-inducible factor-1
expression in the gastric carcinogenesis sequence and its prognostic role in gastric and gastro-oesophageal adenocarcinomas FREE
E A Griffiths, S A Pritchard, H R Valentine, N Whitchelo, P W Bishop, M P Ebert, P M Price, I M Welch and C M L West
Br J Cancer 96: 95-103; advance online publication, December 19, 2006; doi:10.1038/sj.bjc.6603524
Hypoxia-regulated carbonic anhydrase IX expression is associated with poor survival in patients with invasive breast cancer FREE
S A Hussain, R Ganesan, G Reynolds, L Gross, A Stevens, J Pastorek, P G Murray, B Perunovic, M S Anwar, L Billingham, N D James, D Spooner, C J Poole, D W Rea and D H Palmer
Br J Cancer 96: 104-109; doi:10.1038/sj.bjc.6603530
The expression of FHIT, PCNA and EGFR in benign and malignant breast lesions FREE
G Terry, L Ho, P Londesborough, C Duggan, A Hanby and J Cuzick
Br J Cancer 96: 110-117; advance online publication, December 12, 2006; doi:10.1038/sj.bjc.6603512
DNA repair capacity as a possible biomarker of breast cancer risk in female BRCA1 mutation carriers FREE
J Kotsopoulos, Z Chen, K A Vallis, A Poll, P Ainsworth and S A Narod
Br J Cancer 96: 118-125; doi:10.1038/sj.bjc.6603528
Elevated Bmi-1 expression is associated with dysplastic cell transformation during oral carcinogenesis and is required for cancer cell replication and survival FREE
M K Kang, R H Kim, S J Kim, F K Yip, K-H Shin, G P Dimri, R Christensen, T Han and N-H Park
Br J Cancer 96: 126-133; advance online publication, December 19, 2006; doi:10.1038/sj.bjc.6603529
Epidemiology
Birth weight in relation to endometrial and breast cancer risks in Swedish women FREE
M Löf, S Sandin, L Hilakivi-Clarke and E Weiderpass
Br J Cancer 96: 134-136; advance online publication, December 5, 2006; doi:10.1038/sj.bjc.6603504
No link between viral findings in the prostate and subsequent cancer development FREE
J Bergh, I Marklund, C Gustavsson, F Wiklund, H Grönberg, A Allard, O Alexeyev and F Elgh
Br J Cancer 96: 137-139; advance online publication, November 21, 2006; doi:10.1038/sj.bjc.6603480
Stage, grade and morphology of tumours of the colon and rectum recorded in the Oxford Cancer Registry, 1995–2003 FREE
J Green, J Watson, M Roche, V Beral and J Patnick
Br J Cancer 96: 140-142; advance online publication, November 28, 2006; doi:10.1038/sj.bjc.6603499
Estimating the long-term impact of a prophylactic human papillomavirus 16/18 vaccine on the burden of cervical cancer in the UK FREE
M Kohli, N Ferko, A Martin, E L Franco, D Jenkins, S Gallivan, C Sherlaw-Johnson and M Drummond
Br J Cancer 96: 143-150; advance online publication, December 5, 2006; doi:10.1038/sj.bjc.6603501
A prospective study of postmenopausal hormone use and ovarian cancer risk FREE
K N Danforth, S S Tworoger, J L Hecht, B A Rosner, G A Colditz and S E Hankinson
Br J Cancer 96: 151-156; advance online publication, December 19, 2006; doi:10.1038/sj.bjc.6603527
Beyond mammography screening: quality assurance in breast cancer diagnosis (The QuaMaDi Project) FREE
A Katalinic, C Bartel, H Raspe and I Schreer
Br J Cancer 96: 157-161; advance online publication, December 19, 2006; doi:10.1038/sj.bjc.6603506
Wait times for breast cancer care FREE
N Saint-Jacques, T Younis, R Dewar and D Rayson
Br J Cancer 96: 162-168; advance online publication, December 19, 2006; doi:10.1038/sj.bjc.6603523
Gonorrhoea and male bladder cancer in a prospective study FREE
D S Michaud, E A Platz and E Giovannucci
Br J Cancer 96: 169-171; advance online publication, December 12, 2006; doi:10.1038/sj.bjc.6603510
Helicobacter pylori and oesophageal and gastric cancers in a prospective study in China FREE
F Kamangar, Y-L Qiao, M J Blaser, X-D Sun, H Katki, J-H Fan, G I Perez-Perez, C C Abnet, P Zhao, S D Mark, P R Taylor and S M Dawsey
Br J Cancer 96: 172-176; advance online publication, December 19, 2006; doi:10.1038/sj.bjc.6603517
Letters to the Editor
Evaluating the activity of temsirolimus in neuroendocrine cancer FREE
P H O'Donnell and M J Ratain
Br J Cancer 96: 177; advance online publication, December 12, 2006; doi:10.1038/sj.bjc.6603513
Reply: Evaluating the activity of temsirolimus in neuroendocrine cancer FREE
I Duran, M J Moore and L L Siu
Br J Cancer 96: 178-179; advance online publication, December 12, 2006; doi:10.1038/sj.bjc.6603514
Evidence for PDGFRA, PDGFRB and KIT deregulation in an NSCLC patient FREE
T Negri, P Casieri, F Miselli, M Orsenigo, C Piacenza, S Stacchiotti, P Bidoli, P G Casali, M A Pierotti, E Tamborini and S Pilotti
Br J Cancer 96: 180-181; doi:10.1038/sj.bjc.6603542
Book Review
Oncology (2nd edn) FREE
S Direkze
Br J Cancer 96: 182; doi:10.1038/sj.bjc.6603485
The published online date indicates the date that the issue is published online and is the first official publication date of the issue. Each print issue of BJC is published one week after it has been published online.
